NCT04159025View on ClinicalTrials.gov

EBUS-Miniforceps Biopsy Specimen Acquisition for PD-L1 Testing in Nonsmall Cell Lung Cancer

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 8, 2020

Primary Completion Date

February 24, 2022

Study Completion Date

February 25, 2022

Conditions
Non Small Cell Lung CancerNSCLC
Interventions
DEVICE

CoreDx Pulmonary Mini-Forceps

Manufactured by Boston Scientific

Trial Locations (1)

63110

Washington University School of Medicine, St Louis

Sponsors
All Listed Sponsors
collaborator

Boston Scientific Corporation

INDUSTRY

lead

Washington University School of Medicine

OTHER

NCT04159025 - EBUS-Miniforceps Biopsy Specimen Acquisition for PD-L1 Testing in Nonsmall Cell Lung Cancer | Biotech Hunter | Biotech Hunter